By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clovis Oncology 

1871 Folsom Street

Boulder  Colorado  80302  U.S.A.
Phone: n/a Fax: n/a


Company News
Clovis Oncology (CLVS) Announces Second Quarter 2014 Operating Results 8/8/2014 9:06:05 AM
Clovis Oncology (CLVS) To Announce Second Quarter 2014 Financial Results And Host Webcast Conference Call On August 7 7/22/2014 12:21:41 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In TIGER2 Study 6/23/2014 12:19:44 PM
Clovis Oncology (CLVS) Announces First Patient Enrolled In RUCAPANC Study 6/16/2014 10:31:57 AM
Clovis Oncology (CLVS) Shares Drop As Analysts Give Edge To Lung-Cancer Rival 6/4/2014 7:05:16 AM
Clovis Oncology (CLVS) Announces Encouraging Data From Phase 1/2a Study Evaluating Lucitanib In Advanced Solid Tumors 6/2/2014 9:42:46 AM
Clovis Oncology (CLVS)’s CO-1686 Demonstrates Compelling Clinical Activity And Progression-Free Survival (PFS) In Updated Phase 1/2 Study Results In Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) 6/2/2014 9:38:18 AM
Clovis Oncology (CLVS)’s Phase 1 Study Of Rucaparib Demonstrates Compelling Clinical Activity and Safety In Patients With Solid Tumors 6/2/2014 9:36:49 AM
Clovis Oncology (CLVS) Wins Breakthrough Status For Lung Cancer Candidate CO-1686 5/20/2014 7:20:15 AM
Clovis Oncology (CLVS) Announces Clinical Data To Be Presented At 2014 American Society of Clinical Oncology Annual Meeting 5/15/2014 8:02:02 AM